Idun Biologics ApS
Credit rating
Company information
About Idun Biologics ApS
Idun Biologics ApS (CVR number: 43750380) is a company from AALBORG. The company recorded a gross profit of 662.2 kDKK in 2023. The operating profit was -0.1 kDKK, while net earnings were -2.3 kDKK. The profitability of the company measured by Return on Assets (ROA) was -0 %, which can be considered poor and Return on Equity (ROE) was -6.1 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 32.2 %, a level that can be considered to be low. This means a higher proportion of debt in its capital structure, indicating a greater reliance on borrowed funds. Idun Biologics ApS's liquidity measured by quick ratio was 1.5 which is at a high level. Thus, the company is in a strong financial position, with liquid assets surpassing current liabilities. It is well-prepared to cover short-term financial obligations.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2023 | |
---|---|
Volume | |
Net sales | |
Gross profit | 662.22 |
EBIT | -0.05 |
Net earnings | -2.29 |
Shareholders equity total | 37.71 |
Balance sheet total (assets) | 117.28 |
Net debt | -91.31 |
Profitability | |
EBIT-% | |
ROA | -0.0 % |
ROE | -6.1 % |
ROI | -0.1 % |
Economic value added (EVA) | -0.05 |
Solvency | |
Equity ratio | 32.2 % |
Gearing | |
Relative net indebtedness % | |
Liquidity | |
Quick ratio | 1.5 |
Current ratio | 1.5 |
Cash and cash equivalents | 91.31 |
Capital use efficiency | |
Trade debtors turnover (days) | |
Net working capital % | |
Credit risk | |
Credit rating | B |
Variable visualization
Roles
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.